PATENT CLAIM ANALYSIS

Application Number: 15954316
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
RNA interference (RNAi) triggers and RNAi trigger conjugates for inhibiting the expression of Hif2α (EPAS1) gene are described. Pharmaceutical compositions comprising one or more Hif2α RNAi triggers optionally with one or more additional therapeutics are also described. Delivery of the described Hif2α RNAi triggers to tumor cells in vivo provides for inhibition of Hif2α gene expression and treatment of cancer.

Claim (Index 18):
The composition of  claim 1 , wherein said composition is packaged in a kit, container, pack, dispenser, pre-filled syringes, or vials.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 1.63415
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15166311', '15229314', '15071634', '15715765', '15901810']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7829083755808398
- 35 USC 102 Novelty (BERT): 0.6346738939944633
- Combined Prediction Score: 0.7680849274222021
- Mean Citation Score: 376.304652
- Max Citation Score: 599.5658
- Similarity Product: 555.2408859898567

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test